title: Successful adalimumab desensitization after generalized urticaria and rhinitis.
authors.affiliation: Allergy Unit, Hospital Universitario de Getafe, Getafe, Spain. alergologia.hugf@salud.madrid.org
authors.forename: B
authors.initials: B
authors.lastname: Rodríguez-Jiménez
authors.forename: J
authors.initials: J
authors.lastname: Domínguez-Ortega
authors.forename: C
authors.initials: C
authors.lastname: González-Herrada
authors.forename: C
authors.initials: C
authors.lastname: Kindelan-Recarte
authors.forename: P
authors.initials: P
authors.lastname: Loribo-Bueno
authors.forename: N
authors.initials: N
authors.lastname: Garrido-Peño
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy / Q000276:immunology; D012220:Rhinitis / Q000276:immunology / Q000628:therapy*; D014581:Urticaria / Q000276:immunology / Q000628:therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab